|3.||Hirschsprung Disease (Hirschsprung's Disease)
|5.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
|1.||Nowak-Węgrzyn, Anna: 8 articles (12/2015 - 05/2011)|
|2.||Sicherer, Scott H: 7 articles (11/2014 - 04/2003)|
|3.||Shah, Neil: 7 articles (04/2014 - 02/2008)|
|4.||McGuire, William: 6 articles (01/2015 - 01/2008)|
|5.||Colman, Robert W: 6 articles (11/2005 - 07/2002)|
|6.||Ohlsson, Arne: 5 articles (01/2015 - 01/2012)|
|7.||Sampson, Hugh A: 5 articles (11/2014 - 04/2003)|
|8.||Klein, Christoph: 5 articles (04/2014 - 11/2009)|
|9.||McGuire, W: 5 articles (03/2009 - 01/2003)|
|10.||Osborn, D A: 5 articles (01/2007 - 01/2001)|
|1.||Indomethacin (Indometacin)FDA LinkGeneric
12/01/2015 - "Lack of specific, curative treatment for IBD enticed us to investigate the therapeutic efficacy of ethanolic extract of aerial parts of Blumea lacera DC (EEBL) against indomethacin-induced enterocolitis. "
03/01/2011 - "This study was undertaken to investigate the possible effect of hydroalcoholic root extract of Rubia cordifolia against indomethacin-induced enterocolitis in rats. "
12/01/2015 - "The results revealed the protective action of the title plant against the indomethacin-induced enterocolitis in rats, which might be attributed by its antioxidant, anti-inflammatory, antimicrobial, and membrane-stabilizing properties. "
12/01/2015 - "Enterocolitis was induced by two subsequent doses of indomethacin (7.5 mg/kg, s.c) on 7th and 8th day. "
12/01/2015 - "Protective effect of Blumea lacera DC aerial parts in indomethacin-induced enterocolitis in rats."
12/01/2004 - "The aim of the study was to investigate if serum cytokines can distinguish bacterial from viral enterocolitis. "
12/01/2004 - "Serum cytokines in differentiating between viral and bacterial enterocolitis."
11/01/2000 - "In conclusion, increased endogenous PG may be protective against relapsing inflammation in PG-PS induced enterocolitis, at least partially via inhibition of proinflammatory cytokines. "
10/01/1999 - "In conclusion, increased endogenous PG may be protective against relapsing inflammation in PG-PS induced enterocolitis, at least partially via inhibition of proinflammatory cytokines. "
04/01/1994 - "These counterbalancing cytokines are increased in experimental enterocolitis and have important immunoregulatory roles in intestinal inflammation."
|3.||Interleukin-10 (Interleukin 10)IBA
01/01/2013 - "IL-10 deficient animals became moribund on high dose, while tolerated low and Mid doses with significant improved symptoms of enterocolitis. "
03/01/2013 - "We enrolled 40 patients with early-onset enterocolitis and screened for mutations in IL10/IL10R using genetic studies, functional studies, or both of the IL-10 signaling pathway. "
10/01/2015 - "To address this question, we asked whether splenic immune populations were altered in IL-10-deficient (Il10(-/-)) mice in which differences in animal husbandry history were associated with susceptibility to spontaneous enterocolitis that is microbiome dependent. "
01/01/2014 - "Similarly, patients with deleterious mutations in IL10, IL10RA, or IL10RB present with severe enterocolitis within the first months of life. "
02/01/2012 - "Long-term IL-10 gene expression and serum IL-10 levels were observed following AAV transduction in an IL-10-/- model of enterocolitis. "
|4.||Glutamine (L-Glutamine)FDA Link
07/01/1994 - "[Protective effects of glutamine and elemental diet in acute actinic enterocolitis: histological evaluation]."
01/01/1996 - "Experimental studies revealed that glutamine deficiency causes a necrotising enterocolitis and increases the mortality of animals subjected to bacterial stress. "
02/07/2001 - "glutamine modulates cytokine production by immune cells in vitro and protects the gut from experimental enterocolitis, but data on the effect of glutamine on cytokine production in human gut are lacking. "
01/01/2001 - "Although it is considered that L-Glutamine (L-Gln) supplementation improves gut morphology and survival in animal models such as radiation and drug-induced enterocolitis, the mechanisms underlying are far from being established. "
07/01/1990 - "Recent reports have demonstrated that glutamine-supplemented diets ameliorate or reverse many of the adverse effects of experimentally induced enterocolitis. "
|5.||Adrenal Cortex Hormones (Corticosteroids)IBA
01/01/2013 - "Others therapies, namely antenatal corticosteroids and postnatal surfactant, have resulted in significant benefits to infants, including reductions in respiratory distress syndrome, necrotising enterocolitis, intraventricular haemorrhage and neonatal death, but have not impacted favourably on the incidence of BPD, perhaps due to the increased survival of very immature infants. "
05/20/2006 - "Most patients who developed enterocolitis responded to high-dose systemic corticosteroids. "
01/01/2004 - "The most frequent used corticosteroids are bethamethason and dexamethason, with useful effects: acceleration of growth of fetal lungs by ripening pneumocites type II and supression of creating secundary septs; by protection of brain from intraventricular haemorrhage and periventricular leucomalation; decreasing rate of rethinopathy and enterocolitis and ductus artheriosus persistens. "
09/01/1996 - "Nongranulomatous chronic idiopathic enterocolitis: clinicopathologic profile and response to corticosteroids."
01/01/2012 - "Antenatal corticosteroids given in cases of PPROM reduce the incidence of neonatal death, respiratory distress syndrome, intraventricular haemorrhage and necrotising enterocolitis without increasing maternal or neonatal infection. "
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/01/2002 - "Some simple stool tests, such as fecal tumor necrosis factor-alpha and alpha1-antitrypsin determination, might be candidates for diagnostic studies in patients with food protein-induced enterocolitis, if prospectively evaluated. "
04/01/2010 - "We present 2 patients with lymphocytic enterocolitis refractory to usual medical therapy who were treated with tumor necrosis factor antagonists. "
04/01/2010 - "Refractory lymphocytic enterocolitis and tumor necrosis factor antagonist therapy."
01/01/2005 - "The amount of IL-6-producing cells seen in macaques with enterocolitis was significantly higher (P<0.001) than that seen in the healthy control animal, while TNF-alpha- and IL-1-alpha-producing cells were seen only in macaques with enterocolitis. "
05/01/2003 - "TNF-alpha/Stat3 double-mutant mice developed severe chronic enterocolitis with enhanced Th1 cell development. "
|7.||Ceftriaxone (Ceftriaxon)FDA LinkGeneric
06/01/1997 - "If further studies confirm the efficacy of this therapy and the risk of inducing drug resistance is minimal, the epidemiologic problem created by convalescent fecal bacterial carriage may justify a short-course of ceftriaxone therapy for children with Salmonella enterocolitis."
05/01/2003 - "To evaluate the clinical efficacy of a short-course ceftriaxone therapy in the treatment of paediatric patients with severe non-typhoidal Salmonella enterocolitis. "
05/01/2003 - "However, rapid defervescene was found after short-course ceftriaxone therapy in those patients with severe enterocolitis. "
05/01/2003 - "The patients with severe enterocolitis were assigned to treatment with ceftriaxone (50 mg kg(-1) d(-1)) for 3-5 d, while the rest were given supportive treatment only. "
05/01/2003 - "Short-term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella enterocolitis."
|8.||infliximab (Remicade)FDA Link
05/01/2014 - "Herein, we describe a 17-year-old patient with severe DC, manifested by bone marrow failure, severe immunodeficiency, and enterocolitis requiring prolonged infliximab therapy, who developed fatal hepatic failure caused by an aggressive, infiltrating hepatic angiosarcoma. "
05/20/2006 - "Four other patients with steroid-refractory enterocolitis appeared to respond promptly to tumor necrosis factor alpha blockade with infliximab. "
11/01/2008 - "Enterocolitis is the most common immune-related adverse event and may cause severe diarrhea requiring intravenous hydration, high-dose corticosteroids, and blockade of tumor necrosis factor alpha with infliximab. "
09/01/2008 - "We analyzed the protective effects of octreotide and the tumor necrosis factor-alpha inhibitor infliximab in a rat model of indomethacin-induced enterocolitis. "
04/01/2010 - "Tumor necrosis factor-alpha antagonists such as infliximab or adalimumab may be a new treatment option for patients with severe refractory lymphocytic enterocolitis not responding to corticosteroids."
09/01/2015 - "In addition, anti-oxMIF mAbs alleviated disease severity in mouse models of acute and chronic enterocolitis and improved, in synergy with glucocorticoids, renal function in a rat model of crescentic glomerulonephritis. "
12/01/2006 - "Both these measures have been associated with improved outcomes; antepartum glucocorticoids reduce the incidence of respiratory distress syndrome, intraventricular haemorrhage, periventricular leucomalacia and necrotising enterocolitis, and in utero transfer is associated with decreased morbidity and mortality and less hospital-based intervention compared with postnatal transportation. "
09/01/2013 - "The model including all infants with severe ROP comprised screening of infants with GA <30 weeks and/or BW <1250 g and a selection of infants with GA 30-32 weeks and/or BW 1250-1500 g, with at least one of the following risk factors: artificial ventilation (AV), sepsis, necrotising enterocolitis (NEC), postnatal glucocorticoids or cardiotonica. "
09/01/1998 - "Prophylactic oral vancomycin conferred protection against necrotising enterocolitis in preterm, very low birthweight infants and was associated with a 50% reduction in the incidence. "
09/01/1998 - "However, widespread implementation of this preventive measure is not recommended, as it would only be effective in necrotising enterocolitis caused by Gram positive organisms and could increase the danger of the emergence of vancomycin resistant or dependent organisms. "
09/01/1998 - "Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants."
11/01/1988 - "Although this was not a randomised control trial, results indicate a role for vancomycin in prophylaxis of necrotising enterocolitis."
01/01/2013 - "This response required the presence of an intact microbiome, since fish pre-treated with vancomycin developed less severe enterocolitis. "
|1.||Enteral Nutrition (Feeding, Tube)
04/01/1982 - "The incidence of necrotising enterocolitis (NEC) in very low birthweight infants (VLBW less than or equal to 1500 g) was reduced by the delayed onset of enteral feeding. "
01/01/2015 - "Early enteral feeding practices are potentially modifiable risk factors for necrotising enterocolitis (NEC) in very preterm or very low birth weight (VLBW) infants. "
01/01/2014 - "Early enteral feeding practices are potentially modifiable risk factors for necrotising enterocolitis in very preterm or very low birth weight (VLBW) infants. "
08/01/2013 - "In these infants, there is no clear relationship between enteral feeding patterns and the development of necrotising enterocolitis in the post-operative period. "
08/01/2013 - "There were no differences in enteral feeding patterns among the patients who developed necrotising enterocolitis and their matched controls. "
|2.||Neonatal Intensive Care
04/01/2009 - "Our study showed that enteral administration of prophylactic probiotics in neonatal intensive care setup could significantly reduce morbidity due to necrotising enterocolitis in very low birth weight newborn. "
03/01/1998 - "Necrotising enterocolitis is the commonest surgical condition among babies in the neonatal intensive care unit (NICU). "
01/16/1982 - "Neonatal necrotising enterocolitis (NEC) mostly affects the small premature infant in a neonatal intensive care unit (NICU). "
01/01/2002 - "Babies whose mothers had been allocated to the interventionist group had more hyaline membrane disease (RR 2.3, 95% CI 1.39 to 3.81), more necrotising enterocolitis (RR 5.5, 95% CI 1.04 to 29.56) and were more likely to need admission to neonatal intensive care (RR 1.32, 95% CI 1.13 to 1.55) than those allocated an expectant policy. "
08/01/2014 - "To evaluate outcomes in critically ill neonates with necrotising enterocolitis (NEC) undergoing a laparotomy in the neonatal intensive care unit (NICU). "
03/01/1997 - "A 3-day-old male baby with neonatal necrotising enterocolitis had a central line (Cavafex No. 18) inserted through the left femoral vein for administration of parenteral nutrition. "
03/01/1994 - "Owing to concerns about the possible increased risk of necrotising enterocolitis in newborn infants after AREDFV, this group was started on enteral feeds later and was more likely to receive parenteral nutrition than the EDFV group. "
02/01/1987 - "The effects of parenteral nutrition in the treatment of patients with severe chronic radiation enterocolitis is not known. "
02/01/1987 - "[Evaluation of the use of parenteral nutrition in chronic and severe radiation enterocolitis]."
11/01/1982 - "Parenteral feeding and necrotising enterocolitis in very low birthweight infants."
|4.||Drug Therapy (Chemotherapy)
03/01/2008 - "Good results have been reported in the treatment of the complications of chemotherapy and radiation enterocolitis. "
01/01/2015 - "A rare occurrence of hepatic portal venous gas in a patient with chemotherapy-induced enterocolitis: the rise of benign aetiologies."
09/01/2010 - "The authors performed a retrospective review or patients treated at their institution to ascertain the prognostic value of the clinical symptoms and signs of acute enterocolitis, the corresponding abdominal ultrasonographic findings, and the impact of previous chemotherapy. "
05/01/2010 - "Monolayers of human intestinal T(84) epithelial cells and a rat model of chemotherapy-induced enterocolitis were used. "
10/01/2004 - "Chemotherapy-associated enterocolitis is a very rare but potentially lethal side effect of cytostatic therapy. "
|5.||Diet Therapy (Therapy, Diet)
03/01/1981 - "[Effect of diet therapy on pancreatic exocrine function in chronic enterocolitis]."
01/01/1969 - "[Effect of diet therapy on the dynamics of electrolyte metabolism and electrocardiographic indices in patients with chronic enterocolitis]."
01/01/1968 - "[Efficacy of diet therapy in chronic colitis and enterocolitis]."